
Explore the key conclusions around aiming for higher treatment targets, discussed at the UCB-sponsored Satellite Symposium presented at EULAR 2023.
Dr Elena Nikiphorou is a consultant rheumatologist at King’s College Hospital, London, UK, and an adjunct senior lecturer at King’s College London, UK.
Dr Nikiphorou has a clinical and academic interest in inflammatory arthritis, multi-morbidity and long-term outcomes of disease. She has been the recipient of multiple national and international awards, bursaries and competitive roles. She has been involved in the development of several international recommendations, including on the management of difficult-to-treat rheumatoid arthritis, axial spondyloarthritis and self-management strategies in inflammatory arthritis.
Treatment for PsA should target a broad range of musculoskeletal and extra-articular manifestations.1 Listen to Assoc. Prof Philipp Sewerin explain how MDA can...
Explore the key conclusions around aiming for higher treatment targets, discussed at the UCB-sponsored Satellite Symposium presented at EULAR 2023.
axSpA is a complex disease with a significant burden on many aspects of daily life.1,2 Dive into the importance of ASAS40 for your patients with Dr Fabian Proft.
Watch Prof Robert Landewé discuss the importance of using ASDAS <2.1 as a treatment target for patients with axSpA.
Read our key takeaways from the 2022 ASAS-EULAR recommendations for the management of axSpA, presented as part of Dr Sofia Ramiro's workshop at UCB Summit 2023.
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss the role of the IL-17 family of cytokines in SpA pathobiology.